StonvexLoading…
StonvexStonvexStonvexCore line items from SXC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.84B | $1.94B | $2.06B | $1.97B |
Operating Income | $-44.40M | $151.90M | $125.10M | $153.70M |
Net Income | $-44.20M | $95.90M | $57.50M | $100.70M |
EPS (Diluted) | $-0.52 | $1.12 | $0.68 | $1.19 |
Total Assets | $1.79B | $1.67B | $1.66B | $1.65B |
Total Liabilities | $1.16B | $957.20M | $1.01B | $1.03B |
Cash & Equivalents | $88.70M | $189.60M | $140.10M | $90.00M |
Free Cash Flow OCF − CapEx | $42.30M | $95.90M | $139.80M | $133.40M |
Shares Outstanding | 85.50M | 85.30M | 84.90M | 84.60M |